The identification of null MPZ alleles in patients with CMT1B suggests that there is a threshold in the amount of MPZ required for proper myelination [8]; in support of this notion, mice that are heterozygous for an Mpz-knockout allele develop a late-onset peripheral demyelinating neuropathy [9]. The gene discussed is MPZ; the disease is demyelinating polyneuropathy.